1. Boardman, L.A. Heritable colorectal cancer syndromes: Recognition and preventive management. Gastroenterol. Clin. North Am. Dec 2002, 31 (4), 1107-1131.

2. Lynch, H.T.; Smyrk, T.C. Hereditary colorectal cancer. Semin. Oncol. Oct 1999, 26 (5), 478-484.

3. Wallace, M.H.; Phillips, R.K. Preventative strategies for periampullary tumours FAP. Ann. Oncol. 1999, 10 (Suppl. 4), 201-203.

4. Griffioen, G.; Bus, P.J.; Vasen, H.F.; Verspaget, H.W.; Lamers, C.B. Extracolonic manifestations of familial adenomatous polyposis: Desmoid tumours, and upper gastrointestinal adenomas and carcinomas. Scand. J. Gastroenterol. Suppl. 1998, 225, 85-91.

5. Offit, K. Clinical Cancer Genetics: Risk Counseling and Management; Wiley-Liss, Inc.: New York, 1998.

6. Hamilton, S.R.; Liu, B.; Parsons, R.E.; et al. The molecular basis of Turcot's syndrome. N. Engl. J. Med. Mar 30, 1995, 332 (13), 839-847.

7. Hernegger, G.S.; Moore, H.G.; Guillem, J.G. Attenuated familial adenomatous polyposis: An evolving and poorly understood entity. Dis. Colon. Rectum Jan 2002, 45 (1), 127-134. Discussion 134-126.

8. Bisgaard, M.L.; Fenger, K.; Bulow, S.; Niebuhr, E.; Mohr, J. Familial adenomatous polyposis (FAP): Frequency, penetrance, and mutation rate. Human Mutat. 1994, 3

9. Su, L.K.; Vogelstein, B.; Kinzler, K.W. Association of the APC tumor suppressor protein with catenins. Science Dec 10, 1993, 262 (5140), 1734-1737.

10. Sieber, O.M.; Tomlinson, I.P.; Lamlum, H. The adenoma-tous polyposis coli (APC) tumour suppressor-genetics, function and disease. Mol. Med. Today Dec 2000, 6 (12), 462-469.

11. O'Sullivan, M.J.; McCarthy, T.V.; Doyle, C.T. Familial adenomatous polyposis: From bedside to benchside. Am. J. Clin. Pathol. May 1998, 109 (5), 521-526.

12. Giardiello, F.M.; Krush, A.J.; Petersen, G.M.; et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology Jun 1994, 106 (6), 1542-1547.

13. Friedl, W.; Caspari, R.; Sengteller, M.; et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut Apr 2001, 48 (4), 515-521.

14. Nagase, H.; Miyoshi, Y.; Horii, A.; et al. Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res. Jul 15,1992, 52 (14), 4055-4057.

15. Soravia, C.; Berk, T.; Madlensky, L.; et al. Genotype-phenotype correlations in attenuated adenomatous pol-yposis coli. Am. J. Hum. Genet. Jun 1998, 62 (6), 12901301.

16. Caspari, R.; Olschwang, S.; Friedl, W.; et al. Familial adenomatous polyposis: Desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum. Mol. Genet. Mar 1995, 4

17. Olschwang, S.; Tiret, A.; Laurent-Puig, P.; Muleris, M.; Parc, R.; Thomas, G. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell Dec 3,1993, 75 (5), 959 - 968.

18. Wallis, Y.L.; Morton, D.G.; McKeown, C.M.; Macdonald, F. Molecular analysis of the APC gene in 205 families:

Extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. J. Med. Genet. Jan 1999, 36 (1), 14-20.

19. Solomon, C.; Burt, R.W. Familial Adenomatous Polyposis; June 23 2003. Copyright 1997-2003, University of Washington, Seattle. [Database online]. Available at: Accessed December 12, 2003.

20. American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. J. Clin. Oncol. Jun 15, 2003, 21 (12), 2397 -2406.

21. King, J.E.; Dozois, R.R.; Lindor, N.M.; Ahlquist, D.A. Care of patients and their families with familial adenomatous polyposis. Mayo Clin. Proc. Jan 2000, 75 (1), 57 -67.

22. Cruz-Correa, M.; Giardiello, F.M. Diagnosis and management of hereditary colon cancer. Gastroenterol. Clin. North Am. Jun 2002, 31 (2), 537-549x.

23. Kadmon, M.; Tandara, A.; Herfarth, C. Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register. Int. J. Colorectal. Dis. Apr 2001, 16 (2), 63-75.

24. Hawk, E.; Lubet, R.; Limburg, P. Chemoprevention in hereditary colorectal cancer syndromes. Cancer Dec 1, 1999, 86 (11 Suppl.), 2551-2563.

25. Steinbach, G.; Lynch, P.M.; Phillips, R.K.; et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. Jun 29, 2000, 342 (26), 1946-1952.

Fanconi Anemia

Hans Joenje Gerard Pals

Christian Michel Zwaan

VU University Medical Center, Amsterdam, The Netherlands

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment